BioCentury | Apr 27, 2018
Clinical News

DelMar reports Phase II data for VAL-083 in recurrent GBM

...2 IV VAL-083 on days 1-3 of each 21-day cycle for up to 12 cycles. VAL-083...
...U.S. to treat recurrent GBM. VAL-083 is approved in China, where it is known as DAG for Injection...
...myelogenous leukemia (CML) and lung cancer. DelMar Pharmaceuticals Inc. (NASDAQ:DMPI), Vancouver, B.C. Product: DAG for Injection, dianhydrogalactitol (VAL-083...
BioCentury | Sep 15, 2017
Clinical News

DelMar starts Phase II of VAL-083 for MGMT-unmethylated GBM

...DelMar Pharmaceuticals Inc. (NASDAQ:DMPI) began a Phase II trial of VAL-083 to treat newly diagnosed O6-alkylguanine...
...20-30 patients in sequential dose-escalation cohorts to receive 20, 30 or 40 mg/m 2 IV VAL-083...
...Guangxi Wuzhou Zhongheng Group Co. Ltd. (Shanghai:600252). DelMar Pharmaceuticals Inc. (NASDAQ:DMPI), Vancouver, B.C. Product: VAL-083 (DAG for Injection...
BioCentury | Jan 27, 2017
Clinical News

VAL-083: Ph II started

...DelMar began an open-label, U.S. Phase II trial to evaluate 40 mg/m 2 IV VAL-083 on...
...MGMT)-unmethylated, Avastin bevacizumab-naïve recurrent glioblastoma. VAL-083 is approved in China, where it is known as DAG for Injection...
...leukemia (CML) and lung cancer. DelMar Pharmaceuticals Inc. (NASDAQ:DMPI), Vancouver, B.C. Product: DAG for Injection , dianhydrogalactitol (VAL-083...
BioCentury | Sep 19, 2016
Company News

Accurexa, DelMar Pharma deal

...DelMar and Accurexa partnered to develop Accurexa’s ACX-31 implantable polymer wafer to locally deliver DelMar’s VAL-083...
...product candidates and resulting IP for an undisclosed period after the completion of the research. VAL-083...
BioCentury | Jun 22, 2015
Clinical News

DAG for Injection: Additional Phase I/II data

...of >=30 mg/m 2 VAL-083 vs. 4.4 months at doses of <10 mg/m 2 VAL-083. VAL-083...
...Wuzhou Pharmaceutical Co. subsidiary has rights to VAL-083 in China, where it is known as DAG for Injection...
...OTCQX:DMPI), Vancouver, B.C. Guangxi Wuzhou Zhongheng Group Co. Ltd. (Shanghai:600252), Wuzhou, China Product: DAG for Injection ( VAL-083...
BioCentury | May 4, 2015
Clinical News

DAG for Injection: Additional Phase I/II data

...8th cohort of an open-label, U.S. Phase I/II trial showed that 50 mg/m 2 IV VAL-083...
...Wuzhou Pharmaceutical Co. subsidiary has rights to VAL-083 in China, where it is known as DAG for Injection...
...OTCQX:DMPI), Vancouver, B.C. Guangxi Wuzhou Zhongheng Group Co. Ltd. (Shanghai:600252), Wuzhou, China Product: DAG for Injection ( VAL-083...
BioCentury | Nov 24, 2014
Clinical News

DAG for Injection: Additional Phase I/II data

...dose-escalation, U.S. Phase I/II trial showed that doses of up to 40 mg/m 2 IV VAL-083...
...Wuzhou Pharmaceutical Co. subsidiary has rights to VAL-083 in China, where it is known as DAG for Injection...
...OTCQX:DMPI), Vancouver, B.C. Guangxi Wuzhou Zhongheng Group Co. Ltd. (Shanghai:600252), Wuzhou, China Product: DAG for Injection ( VAL-083...
BioCentury | Sep 1, 2014
Clinical News

DAG for Injection: Phase I/II amended

...a protocol amendment to FDA to add 50 and 60 mg/m 2 doses of IV VAL-083...
...Wuzhou Pharmaceutical Co. subsidiary has rights to VAL-083 in China, where it is known as DAG for Injection...
...OTCBB:DMPI), Vancouver, B.C. Guangxi Wuzhou Zhongheng Group Co. Ltd. (Shanghai:600252), Wuzhou, China Product: DAG for Injection ( VAL-083...
BioCentury | Jul 21, 2014
Clinical News

DAG for Injection: Additional Phase I/II data

...6th cohort of an open-label, U.S. Phase I/II trial showed that 30 mg/m 2 IV VAL-083...
...Wuzhou Pharmaceutical Co. subsidiary has rights to VAL-083 in China, where it is known as DAG for Injection...
...OTCBB:DMPI), Vancouver, B.C. Guangxi Wuzhou Zhongheng Group Co. Ltd. (Shanghai:600252), Wuzhou, China Product: DAG for Injection ( VAL-083...
BioCentury | Apr 21, 2014
Clinical News

VAL-083: Additional Phase I/II data

...I/II trial showed that 1.5, 3, 5, 10 and 20 mg/m 2 doses of IV VAL-083...
...Wuzhou Pharmaceutical Co. subsidiary has rights to VAL-083 in China, where it is known as DAG for Injection...
...OTCBB:DMPI), Vancouver, B.C. Guangxi Wuzhou Zhongheng Group Co. Ltd. (Shanghai:600252), Wuzhou, China Product: VAL-083 ( DAG for Injection...
Items per page:
1 - 10 of 17